Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 36%
Sell 7%
Strong Sell 0%

Bulls say

Henry Schein is a well-established company with a strong reputation in the dental market and potential for growth in the medical market. It is focused on reducing costs and expanding margins and has a respected leadership team with a clear growth plan. Despite some concerns about declining dental coverage and security risks, HSIC is expected to continue growing and is a solid choice for investors.

Bears say

Henry Schein is a well-known and dominant player in the healthcare distribution industry, serving a diversified and global customer base. However, the company's 2026 and 2027 projected increase in EBITDA seems relatively small compared to its cost reduction initiatives and the potential for price increases. Additionally, the company's heavy reliance on its Global Distribution and Value-Added Services segment and the potential threats of tariffs and changing healthcare policies may pose risks to its growth. With a relatively low valuation compared to its peers, Henry Schein's stock may be volatile and may not attract potential investors.

Henry Schein (HSIC) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 36% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Buy based on their latest research and market trends.

According to 14 analysts, Henry Schein (HSIC) has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.